The BladderScan BVM 6500 enables physicians quickly and noninvasively to determine UEBW (ultrasound estimated bladder weight) and bladder volume using 3-dimensional V-mode ultrasound. The BVM 6500 wa
... leading bulking therapy, is the least invasive im...ncontinence (SUI). Natural collagen protein adds b...on in a defective internal sphincter. Compatible w...en Implant forms a soft network of fibers, inducin...
The Titan™ Inflatable Penile Prosthesis (IPP) is a hydraulic system designed to be surgically implanted into the penis for the management of erectile dysfunction (also known as impotence). This
...e penile prostheses offer easy-to-use, low-cost op...ed dexterity. These implants are always rigid, but...them in an erect or concealed position. Designed t...se and to not interfere with pleasurable sensation...
Medicine Products:(Date:10/7/2008)...ASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- The C...HA) -- in conjunction with Catholic,Health Initiat...gton, MA;,and Trinity Health, Novi, MI -- is launc...ut global climate change., Through receipt of a $...ip for the Environment (NRPE) and the Catholic Coa...
(Date:10/7/2008)...http://www.boomj.com Featuring Daily Articles on ...n and Charities, HENDERSON, Nev., Oct. 7 /PRNewsw... BOMJ) http://www.BOOMj.com, the leading social ...ver the age of 35 today announced,its commitment t... (Logo: http://www.newscom.com/cgi-bin/prnh/20070...
(Date:10/7/2008)...NTONY, France, October 7 /PRNewswire-FirstCall/ --...entered into an exclusive agreement with,Catalent ...renaline,autoinjector, ADREFLEX(R), co-developed a...se PLC., ADREFLEX(R) consists of a syringe pre-fi...adult and paediatric use (0.3 and 0.15 mg), in an,...
(Date:10/7/2008)...ITTSBURGH, Oct. 7 /PRNewswire/ -- MED3OOO Group, I...agement and technology products and,services for p...Hoffman to,the position of Chief Compliance and Et...ce in healthcare which includes over 10 years in,h...s role, Ms. Hoffman will be responsible for the ov...
Breaking Medicine News(10 mins):Health News:Catholic Health Organizations Launch Ministry-Wide Effort to Raise Awareness About Global Climate Change 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 3Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:MED3OOO Appoints Angela Hoffman as Chief Compliance Officer 2(Date:10/6/2008)...al Associations Collaborate to Improve Patient Saf...- The American College of,Cardiology in collaborat...and the American Heart Association today released ... for reducing the risk of ulcers and,gastrointesti...l,anti-inflammatory drugs (NSAIDs) along with anti...
(Date:10/6/2008)...C Trial Showed REMICADE Therapy is More Likely to ...g Compared with Standard Immun...- Data presented for the first time,f...sease Naive to,Immunomodulators and Biologic Thera...ach to care of patients with moderate to severe Cr...
(Date:10/6/2008)...percent of moderate to severe patients achieved en...d endoscopic remission at Week 10,in data from a 5...College,of Gastroenterology (ACG) Annual Scientifi...UCB today presented data from a,large, prospective...hn,s,disease (CD) with a biologic compound. The da...
(Date:10/6/2008)...ocedure May Eliminate 6 Weeks of Radiation Therapy...ver the Internet Wednesday, October 22, 2008, 3...orehealth , HAMPTON, Va., Oct. 6 / Q...as diagnosed with breast cancer in May. Would she ...bout radiation or chemotherapy?, , To view the M...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Argonne researchers win 2 R 26amp 3BD 100 Awards 6632 1Argonne researchers win 2 R 26amp 3BD 100 Awards 6632 2Argonne researchers win 2 R 26amp 3BD 100 Awards 6632 3Argonne researchers win 2 R 26amp 3BD 100 Awards 6632 4Nanosculpture could enable new types of heat pumps and energy converters 6629 1Nanosculpture could enable new types of heat pumps and energy converters 6629 2Blue Shield Settlement with Regulators Timed to Fend Off L A City Attorneys Lawsuit 24164 1Predicting the distribution of creatures great and small 4109 1Predicting the distribution of creatures great and small 4109 2...WARRINGTON, Pa., May 31, 2007 (PRIME NEWSWIRE) -- ...es publication of the,one-year follow-up results f...r Surfaxin(r), in Pediatrics, the premier medical,...e long-term data,from the SELECT and STAR trials c...y significant survival advantage,relative to exist...
...ASADENA, Calif.--(BUSINESS WIRE)--Jun 1, 2007 - Ar...ed today that interim Phase I data,has been publis...logy Proceedings (ASCO) (Abstract ID 32638). The d...igned to evaluate the safety,tolerability, and ph...ate, IT-101, in patients with inoperable or metast...
Other Medicine Technology:Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 2Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 3Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 4Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 5Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from,Human Clinical Trials for New Cancer Drug 2Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from,Human Clinical Trials for New Cancer Drug 3